Tenediar Sustained-Release Tablet 10/750 mg
Metformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genupharm Co., Ltd.
MFDS item code 202202732 · Approved 2022.07.01
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps patients with type 2 diabetes manage their blood sugar more effectively in conjunction with diet and exercise. The combined action of teneligliptin and metformin aids in improving blood sugar levels. Therefore, it is used for enhancing blood sugar control in the treatment of diabetes.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.
This medication is used for the treatment of diabetes and may rarely cause a dangerous condition called lactic acidosis. Lactic acidosis is a complication resulting from the excessive buildup of lactic acid in the body; if symptoms occur, immediate notification to medical personnel is necessary. This medication should not be administered to patients with moderate to severe kidney impairment, or severe diseases such as heart failure, acute myocardial infarction, or sepsis. Additionally, it should be temporarily discontinued before and after examinations using iodinated contrast media, and resumed only after normal kidney function is confirmed. It is also not recommended for use in pregnant women or those who may become pregnant, patients with severe liver dysfunction, or patients in poor general condition due to severe infections or trauma. Caution should be exercised when taking this medication with insulin or sulfonylurea medications as the risk of hypoglycemia may increase; blood sugar levels and symptoms should be monitored closely. If hypoglycemic symptoms occur, immediate action should be taken by consuming sugar. Patients with a history of abdominal surgery or bowel obstruction, those with a history of heart arrhythmias such as QT interval prolongation, or suspected symptoms of acute pancreatitis should be administered this medication carefully. Caution is required as the risk of lactic acidosis may increase in patients with liver dysfunction, pulmonary embolism, severe pulmonary dysfunction, excessive alcohol consumption, dehydration, diarrhea, or vomiting. Regular monitoring of kidney function and blood tests should be conducted during treatment, particularly in elderly patients or those with reduced kidney function. Pregnant or breastfeeding women should avoid this medication, and those who are breastfeeding should decide on the use of this medication after consulting with their physician. In case of overdose, appropriate treatment should be sought immediately at a medical institution, and some of this medication can be removed by hemodialysis. The safety and efficacy of this medication in children have not been established, so it should not be used in this population. When using this medication, it should be stored out of reach of children and should not be transferred to other containers. While taking this medication, side effects such as dizziness, constipation, abdominal pain, abnormal liver function, skin rash, acute pancreatitis, etc., may occasionally occur, so if any unusual symptoms arise, consult a physician immediately. Additionally, there may be interactions when used with certain drugs, so if other medications are being taken, it is essential to inform the physician or pharmacist. This medication aids in blood sugar control and should be taken alongside regular meals and exercise. Care should always be taken regarding the symptoms of hypoglycemia and lactic acidosis during treatment.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture, and it should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent degradation.
Yellow oval-shaped sustained-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genupharm Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Ditosylate Dihydrate 37.84mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Ditosylate Dihydrate 18.92mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.